Overview of interim findings from a Survey on Patient Attitudes Toward Clinical Trial Processes In Chronic Liver Diseases
Boston, MA, United States 2023
American Association for the Study of Liver Diseases.
Glp1-agonist reduces alcohol intake and liver inflammation in a mouse model of alcohol-induced acute hepatitis.
Boston, MA, United States 2023
American Association for the Study of Liver Diseases
Sex-based Disparities in Baseline Characteristics and Clinical Outcomes of patients with Decompensated Cirrhosis and Hepatic Hydrothorax
Boston, MA, United States 2023
American Association for the Study of Liver Diseases
Prevalence of nonalcoholic fatty liver disease among adults with normal weight, overweight and obesity in the United States, 1999-2018.
San Diego, CA, United States 2023
Obesity Week
A Case of Late-Onset Hepatic Sinusoidal Obstructive Syndrome/ Veno-occlusive Disease 1 Year Post Transplant.
Vancouver, BC, Canada 2023
American College of Gastroenterology Annual Meeting
Regional Variation in Baseline Characteristics and Clinical Outcomes of Decompensated Cirrhosis with Hepatic Hydrothorax
Vancouver, BC, Canada 2023
American College of Gastroenterology.
Alcohol and Liver Health
Hamden, CT, United States 2023
American Liver Foundation Youth Education Series
Hepatic hydrothorax portends worse inpatient outcomes in patients with decompensated cirrhosis
Chicago, IL, United States 2023
Digestive Diseases Week
Pathways to GI Panel
Virtual panel 2023
Morehouse School of Medicine GI Speaker Series
Teens to Twenties Liver Wellness Guide
Durham, CT, United States 2023
American Liver Foundation Youth Education Series
Metabolic features associated with nonalcoholic fatty liver disease among Asian-Americans, 2012-2018
Washington, DC, United States 2022
American Association for the Study of Liver Diseases
Insulin resistance trends among lean patients with nonalcoholic fatty liver disease in the United States
Washington, DC, United States 2022
American Association for the Study of Liver Diseases
Prognostic mitochondrial ribosomal protein MRPS30 expression in liver cancer: toward new biomarkers in metabolic liver disease
Hartford, CT, United States 2022
American College of Physicians Connecticut Chapter Annual Meeting
Pharmacotherapy for Weight loss in cirrhosis: A case series of GLP-1 agonist-associated weight loss
Virtual Presentation 2021
Obesity Week
New Frontiers for Fatty Liver Disease: Updates on Clinical Trials and Drug Approval Status
Virtual Talk 2021
American Liver Foundation Speaker Series
STEM Professionals Speaker Series
Virtual panel 2021
Cullen Lab and UNCF
Transient Elastography and FIB-4 Identify Portal Hypertension in Patients with Chronic Liver Disease
Boston, MA, United States 2019
American Association for the Study of Liver Diseases
Haptoglobin 2 allele is associated with increased risk and severity of alcoholic hepatitis
San Diego, CA, United States 2019
Digestive Diseases Week
Non-alcoholic fatty liver disease is associated with QTc lengthening in the general population
Vienna, Vienna, Austria 2019
European Association for the Study of the Liver Conference
Enlarging Ectopic Thyroid in the Porta Hepatis
Philadelphia, PA, United States 2018
American College of Gastroenterology Annual Conference
Acceleration of NASH in a mouse model provides novel insights on the mechanisms by which I148M PNPLA3 drives steatohepatitis
Paris, IDF, France 2018
European Association for Study of the Liver
The Physiological, Pathological and Molecular Basis of Nonalcoholic Steatohepatitis Associated Cardiomyopathy
Washington, DC, United States 2017
American Association for Study of Liver Diseases
Key molecular signatures of disease development and progression in non-alcoholic fatty liver disease in humans.
Amsterdam, NH, Netherlands 2017
European Association for Study of Liver Diseases
Collagen formation and degradation biomarkers identify advanced fibrosis in NASH patients
Amsterdam, NH, Netherlands 2017
European Association for the Study of the Liver Conference
Nonalcoholic Steatohepatitis (NASH) has surpassed Hepatitis C as the leading etiology for listing for liver transplant: implications for NASH in children and young adults
Las Vegas, NV, United States 2016
American College of Gastroenterology Annual meeting
Omega-3 Carboxylic Acids, Epanova®, and the Sodium-Glucose Co-transporter 2 Inhibitor, Dapagliflozin®, improve steatohepatitis and fibrosis scoring in a mouse model of NASH
Barcelona, CT, Spain 2016
European Association for the Study of the Liver Conference
Characterization of sulfatase 2 domains regulating Wnt pathway activity in hepatocellular cancer
Bethesda, MD, United States 2014
Network of Minority Health Research Investigators Annual Meeting
Colorectal Cancer Screening Among Outpatients at a Community-Based Teaching Hospital
Wilmington, DE, United States 2012
Mid-Atlantic Meeting of the Society of General Internal Medicine
Increasing Fetal Hemoglobin as Therapy for Sickle Cell Disease
Harrisburg, PA, United States 2006
Joint Conference of the Pennsylvania Public Health Association and the Public Health Institute
Early Sodium Butyrate Treatment Maximally Increases Fetal Hemoglobin in Differentiating Adult Erythroid Cells
Philadelphia, PA, United States 2006
Translational Medicine Symposium
Effect of Thyroid Hormone on Erythroid Maturation of Human Hematopoietic Progenitors
Philadelphia, PA, United States 2006
Sigma Xi Student Research Day
Studies of Globin-Gene Regulation through Examination of Gene Expression Profiling and Chromatin Occupancy.
Philadelphia, PA, United States 2005
Translational Medicine Symposium
Identification of Regulators of Globin-Gene Expression through Studies of Chromatin Occupancy.
Philadelphia, PA, United States 2005
Sigma Xi Student Research Day
Disruption of Gαs Signaling Alters Courtship Memory in Drosophila
Philadelphia, PA, United States 2001
Kimmel Cancer Center Annual Conference